輸入代號或公司名稱後按 Enter
4726

永昕

-0.35 (-1.53%)最後更新 2026-09-15
台灣 · 上櫃 · 生技醫療業
22.6082成交張數本益比3.32股價淨值比0.00%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入 · 未來期間為分析師共識預估(2026-09-09)

營業收入2025740年增 +8.2%
毛利率2025-24.5%最新一期
營業利益率2025-54.6%最新一期
每股盈餘2025-2.17
會計項目走勢20162017201820192020202120222023202420252026 預估 1 家
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計79.9%56.1%93.3%66.1%72.0%82.2%115.5%157.5%135.3%124.5%
營業毛利(毛損)20.1%43.9%6.7%33.9%28.0%17.8%-15.5%-57.5%-35.3%-24.5%
營業毛利(毛損)淨額20.1%43.9%6.7%33.9%28.0%17.8%-15.5%-57.5%-35.3%-24.5%
推銷費用4.8%7.8%10.1%9.2%6.8%7.2%5.9%9.2%7.9%5.9%
管理費用15.5%12.9%17.7%10.6%7.3%10.1%15.4%14.1%12.9%14.1%
研究發展費用108.6%61.3%130.6%72.8%7.0%12.4%19.7%11.6%11.4%10.3%
預期信用減損損失(利益)0.8%0.3%1.6%-0.9%4.3%-0.2%0.0%-0.2%
營業費用合計128.9%82.0%159.2%92.8%22.7%28.8%45.2%34.8%32.2%30.0%
營業利益(損失)-108.9%-38.1%-152.5%-58.9%5.3%-11.0%-60.8%-92.3%-67.5%-54.6%-25.5%
利息收入0.2%0.0%0.5%2.7%1.2%0.4%
其他收入31.5%7.8%12.7%3.1%0.6%0.3%0.8%1.1%1.9%1.6%
其他利益及損失淨額-1.5%-34.2%4.8%-2.6%-1.8%-0.3%-1.0%-10.8%1.9%-1.4%
財務成本淨額0.1%0.5%0.1%0.3%2.6%4.2%4.4%4.5%
採用權益法認列之關聯企業及合資損益之份額淨額-0.1%-1.3%-1.9%-2.9%
營業外收入及支出合計30.0%-26.4%17.4%0.1%-1.1%-0.3%-2.4%-12.5%-1.2%-6.8%
稅前淨利(淨損)-78.8%-64.6%-135.2%-58.8%4.2%-11.3%-63.2%-104.8%-68.7%-61.3%
所得稅費用(利益)合計0.2%-5.4%-5.4%-3.0%-0.4%0.3%-1.3%-0.2%-0.4%-0.7%
繼續營業單位本期淨利(淨損)-79.0%-59.1%-129.8%-55.8%4.7%-11.6%-61.9%-104.6%-68.3%-60.6%
本期淨利(淨損)-79.0%-59.1%-129.8%-55.8%4.7%-11.6%-61.9%-104.6%-68.3%-60.6%
確定福利計畫之再衡量數-0.3%-0.4%1.0%1.0%0.0%-0.0%0.1%0.0%0.0%0.0%
與不重分類之項目相關之所得稅-0.0%-0.1%0.2%1.0%0.4%-0.4%-0.4%0.0%0.0%0.0%
不重分類至損益之項目:2.9%9.3%1.4%-0.5%0.0%0.0%0.0%
國外營運機構財務報表換算之兌換差額-0.0%0.0%-0.0%
與可能重分類之項目相關之所得稅-0.0%0.0%-0.0%
後續可能重分類至損益之項目:-0.0%0.0%-0.0%
其他綜合損益(淨額)-0.2%-0.3%-0.3%2.9%9.3%1.4%-0.5%0.0%0.1%-0.0%
本期綜合損益總額-79.2%-59.5%-130.1%-52.9%13.9%-10.2%-62.5%-104.6%-68.2%-60.6%
母公司業主(淨利∕損)-104.6%-68.3%-60.6%-24.9%
母公司業主(綜合損益)-104.6%-68.2%-60.6%
基本每股盈餘-0.7%-0.5%-1.2%-0.4%0.0%-0.1%-0.4%-0.5%-0.3%-0.3%-0.1%
稀釋每股盈餘0.0%-0.1%-0.4%-0.5%-0.3%-0.3%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-1.1%3.0%9.7%1.0%-1.0%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。最右邊的預估欄是分析師共識預估(2026-09-09),營收、營業利益、母公司淨利、每股盈餘直接取共識平均,毛利由共識營收乘上共識毛利率推算,不是公司財測。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。